1401 - 1425 of 7665 Results
Title
Year
-
RESTRICTEDTitle: Impact of Visual Impairment on Vision-Related Quality of Life in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 5Start Page: 1633End Page: 1643Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-213143Citation Count: 2
-
RESTRICTEDTitle: Pedunculopontine Nucleus Dysconnectivity Correlates With Gait Impairment in Parkinson’s Disease: An Exploratory StudyJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.874692Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.874692/pdfCitation Count: 2
-
RESTRICTEDTitle: Comprehensive short and long read sequencing analysis for the Gaucher and Parkinson’s disease-associated GBA geneJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42003-022-03610-7Best OA location URL: https://www.nature.com/articles/s42003-022-03610-7.pdfCitation Count: 14
-
RESTRICTEDTitle: Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1779End Page: 1781Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29132Citation Count: 7
-
RESTRICTEDTitle: European Academy of Neurology/Movement Disorder Society ‐ European Section guideline on the treatment of Parkinson's disease: I. Invasive therapiesJournal Name: European Journal of NeurologyPublisher: WileyVol: 29Issue #: 9Start Page: 2580End Page: 2595Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/ene.15386Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.15386Citation Count: 24
-
RESTRICTEDTitle: Structural connectivity alterations in the motor network of patients with scans without evidence of dopaminergic deficit (SWEDD)Journal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 11Start Page: 5926End Page: 5933Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-022-11259-9Citation Count: 0
-
RESTRICTEDTitle: A multiplex pedigree with pathologically confirmed multiple system atrophy and Parkinson’s disease with dementiaJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 4Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcac175Best OA location URL: https://academic.oup.com/braincomms/article-pdf/4/4/fcac175/45028340/fcac175.pdfCitation Count: 3
-
RESTRICTEDTitle: Are Virtual Objective Assessments of Fall‐Risk Feasible and Safe for People with Parkinson's Disease?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 6Start Page: 799End Page: 804Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13494Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13494Citation Count: 3
-
RESTRICTEDTitle: Gut instincts in neuroimmunity from the eighteenth to twenty-first centuriesJournal Name: Seminars in ImmunopathologyPublisher: Springer Science and Business Media LLCVol: 44Issue #: 5Start Page: 569End Page: 579Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1007/s00281-022-00948-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00281-022-00948-2.pdfCitation Count: 7
-
RESTRICTEDTitle: Power and Sample Size for Longitudinal Models in R -- The longpower Package and Shiny AppJournal Name: The R JournalPublisher: The R FoundationVol: 14Issue #: 1Start Page: 264End Page: 282Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.32614/rj-2022-022Best OA location URL: https://journal.r-project.org/articles/RJ-2022-022/RJ-2022-022.pdfCitation Count: 7
-
RESTRICTEDTitle: Therapeutic deep brain stimulation disrupts movement-related subthalamic nucleus activity in parkinsonian miceJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.75253Best OA location URL: https://doi.org/10.7554/elife.75253Citation Count: 23
-
RESTRICTEDTitle: A biological classification of Huntington's disease: the Integrated Staging SystemJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 7Start Page: 632End Page: 644Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00120-xBest OA location URL: https://discovery.ucl.ac.uk/10151755/1/21.08.12%20HD-ISS%20Manuscript%20final%20submitted.pdfCitation Count: 86
-
RESTRICTEDTitle: Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseasesJournal Name: Progress in NeurobiologyPublisher: Elsevier BVVol: 214Issue #:Start Page: 102270End Page: 102270Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.pneurobio.2022.102270Best OA location URL: https://doi.org/10.1016/j.pneurobio.2022.102270Citation Count: 89
-
RESTRICTEDTitle: An MDS Evidence‐Based Review on Treatments for Huntington's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1566End Page: 1567Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29059Citation Count: 0
-
RESTRICTEDTitle: Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 7Start Page: 652End Page: 652Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1166Best OA location URL: https://air.unimi.it/bitstream/2434/943394/2/Le%20Guen%20et%20al.pdfCitation Count: 35
-
RESTRICTEDTitle: CD11b agonists offer a novel approach for treating lupus nephritisJournal Name: Translational ResearchPublisher: Elsevier BVVol: 245Issue #:Start Page: 41End Page: 54Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.trsl.2022.03.001Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167730Citation Count: 11
-
RESTRICTEDTitle: Clinical profiles and outcomes of deep brain stimulation in G2019S LRRK2 Parkinson diseaseJournal Name: Journal of NeurosurgeryPublisher: Journal of Neurosurgery Publishing Group (JNSPG)Vol: 137Issue #: 1Start Page: 184End Page: 191Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3171/2021.7.jns21190Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117559Citation Count: 4
-
RESTRICTEDTitle: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 7Start Page: 726End Page: 726Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1601Citation Count: 0
-
RESTRICTEDTitle: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease—ReplyJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 7Start Page: 726End Page: 726Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1604Citation Count: 0
-
RESTRICTEDTitle: Convergence of signalling pathways in innate immune responses and genetic forms of Parkinson’s diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 169Issue #:Start Page: 105721End Page: 105721Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105721Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105721Citation Count: 6
-
RESTRICTEDTitle: Deep learning architectures for Parkinson's disease detection by using multi-modal featuresJournal Name: Computers in Biology and MedicinePublisher: Elsevier BVVol: 146Issue #:Start Page: 105610End Page: 105610Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.compbiomed.2022.105610Citation Count: 16
-
RESTRICTEDTitle: Diabetes and Neuroaxonal Damage in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1568End Page: 1569Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.29067Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29067Citation Count: 5
- Editor's Note2022
-
RESTRICTEDTitle: European Academy of Neurology/Movement Disorder Society‐European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive TherapiesJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1360End Page: 1374Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29066Best OA location URL: https://digital.csic.es/bitstream/10261/306772/1/Invasive-Therapies.pdfCitation Count: 61
-
RESTRICTEDTitle: Generation of homozygous PRKN, PINK1 and double PINK1/PRKN knockout cell lines from healthy induced pluripotent stem cells using CRISPR/Cas9 editingJournal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 62Issue #:Start Page: 102806End Page: 102806Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.scr.2022.102806Best OA location URL: https://doi.org/10.1016/j.scr.2022.102806Citation Count: 8